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Replicative senescence in patients with chronic kidney failure
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Replicative senescence in patients with chronic kidney failure.
Background. Chronic activation of immunocompetent cells
may lead to stress-induced premature senescence (SIPS); these
senescent cells are characterized by a decrease in telomere
length. The present study evaluates SIPS in circulating immuno-
competent cells from predialysis patients, patients on hemodial-
ysis, and in renal transplant patients with normal renal function.
Methods. Determination of telomere length by flow-
fluorescence in situ hybridization (FISH), expression of surface
molecules, and evaluation of apoptosis was performed by flow
cytometry.
Results. In uremic predialysis patients, we observed a sub-
population of lymphocytes with short telomeres. However, in
this population of patients we did not observe SIPS mononu-
clear cells. In hemodialysis patients, we found a subpopulation
of SIPS mononuclear cells that also showed phenotypic changes
of proinflammatory activity. Finally, transplant patients with
normal renal function also exhibited a subpopulation of SIPS
lymphocytes, which can be attributed to chronic lymphocyte
activation induced by the major histocompatibility complex.
Conclusion. In chronic kidney disease patients, immunocom-
petent cells undergo SIPS, a process associated with chronic cell
activation and induced by numerous stimuli including uremia,
hemodialysis membranes, and bacterial products. Because SIPS
immunocompetent cells are activated cells with proinflamma-
tory features and live longer in peripheral blood, it is likely that
SIPS cells contribute significantly to the chronic inflammatory
state of patients with advanced renal failure.
The inflammatory process is inherent to the immune
response induced by injury. When the inflammatory re-
sponse is excessive or inappropriately controlled, it may
result in a chronic systemic inflammatory state with un-
desired deleterious consequences. Despite advances in
end-stage renal disease therapy, it is recognized that 30%
to 50% of hemodialysis patients have chronic inflamma-
tion. This may be caused by various factors, some of which
are related to dialysis and some of which are not. Chronic
inflammation in chronic kidney disease (CKD) patients
is evidenced by high levels of C-reactive protein and by
the presence of proinflammatory cytokines [1–3].
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It is well established that activation of immunocom-
petent cells by cytokines or other stimuli may prevent
the initiation of the apoptotic program [4, 5]. Thus, ac-
tivated immunocompetent cells may survive longer in
the bloodstream (Fig. 1). The question we addressed in
the present study was whether these surviving cells share
the characteristics of stress-induced premature senescent
cells.
STRESS-INDUCED PREMATURE SENESCENCE
A general characteristic of the aging process is a pro-
gressive deterioration of organ function that becomes
pathologic with time. It is generally accepted that the
decline in cell function with age causes an inability to
resist internal or environmental stressors. Thus, internal
homeostasis is no longer maintained within physiologic
parameters when the aging organism is faced with stress
[6, 7].
At the cellular level, the accumulation of injuries
causes aging. As a corollary, some evidence of premature
cell senescence should be observed if cell damage is ar-
tificially increased by sublethal doses of stressing agents.
Cell irradiation or oxidative damage results in acceler-
ated cellular senescence, which suggests the presence of
stress-induced premature senescence (SIPS) [6, 7]. Cells
entering the SIPS process become exhausted and remain
in a post-replicative state with a progressive decline in cell
function that eventually results in cessation of cell divi-
sion or growth. These cells may remain in this viable, non-
dividing state for months. Theoretically, accumulation of
SIPS cells over time may contribute to the pathologic
features of aging. For instance, human diploid fibroblasts
exposed in vivo and in vitro to proinflammatory cytokines
display biomarkers of senescence and might participate
in the degradation of the extracellular matrix observed
with aging. Furthermore, chronically stressed lympho-
cytes from acquired immune deficiency syndrome [8] and
lupus patients [9] cause immune dysfunction.
Inasmuch as the SIPS process involves changes to al-
most every aspect of cell function and morphology, cel-
lular senescence is characterized by specific molecular,
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Fig. 1. Factors that are potentially involved
in chronic activation and development of SIPS
of lymphocyte and monocytes in uremic and
hemodialyzed patients.
phenotypic, and functional changes. At the molecular
level, one of the markers of senescence is telomere short-
ening. Accelerated telomere shortening is observed in the
majority of cells undergoing SIPS. Human telomeres are
simple repeats of the sequence, TTAGGG; in somatic
cells, telomeres shorten with each round of replication
[10, 11]. It is widely accepted that telomere shortening
is a universal mechanism that limits the proliferative po-
tential of normal cells that lack endogenous telomerase.
Telomerases are enzymes that replace the telomeric se-
quence lost with each cell replication. Most human ma-
ture cells do not express high levels of telomerase activity
and suffer from a progressive erosion of telomeres dur-
ing each replication. There is a critical level of telomere
shortening at which cells enter a post-replicative senes-
cent state.
Stress-induced premature senescent cells also ex-
hibit other functional and morphologic changes: b-
galactosidase activity is increased, mitochondrial DNA
is deleted, and SIPS mononuclear cells change from
CD14bright/CD16dim to CD14dim/CD16bright [10–13].
Previous studies have shown an association between
the deterioration of renal function and the degree of
kidney senescence as assessed by renal cell telomere
shortening [14]. In advanced renal failure, the immune
response is altered, which is partly responsible for the
increased mortality rate observed among these patients.
As a consequence of chronic cell activation, alterations in
the immune response may be associated with premature
senescence of immunocompetent cells. Therefore, it is
reasonable to hypothesize that, in renal failure patients,
immunocompromised cells might undergo SIPS. To in-
vestigate this hypothesis, we measured telomere length in
monocytes and lymphocytes from CKD stage 4, dialysis,
and transplant patients.
SIPS IN UREMIC PREDIALYSIS PATIENTS
We have shown that uremia induces lymphocyte cell
activation, which is one of the features of the abnor-
mal immune response observed in uremic patients [15].
Extending this line of investigation, we measured telom-
ere length in lymphocytes from uremic patients. The
results show the presence of a subpopulation of lympho-
cytes with short telomeres (Fig. 2). It is likely that a large
proportion of SIPS lymphocytes are CD4 cells with Th1
activity, because this type of lymphocyte is activated in
uremic patients.
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Fig. 2. Representative histogram of telom-
ere length in monocyte cells and lympho-
cytes from one of the uremic (predialysis) pa-
tients evaluated in the present study. There are
two populations of lymphocytes showing long
and short telomeres, respectively. Mononu-
clear cells are a single population of cells with-
out short telomeres.
SIPS IN MONONUCLEAR CELLS FROM
HEMODIALYSIS PATIENTS
The subpopulation of lymphocytes with short telom-
eres is absent in patients on regular hemodialysis ther-
apy, which supports the concept that there are other
factors involved in lymphocyte SIPS. However, we found
that in hemodialysis patients who were dialyzed with
cellulosic membranes, a subset of mononuclear cells ex-
hibits characteristics of SIPS such as decreased telomere
length and a predominant CD14dim/CD16bright pheno-
type [16] (Fig. 3). These findings are explained by the
fact that uremic patients undergo hemodialysis procedure
3 times weekly, activating mononuclear cells at regular
intervals. Consequently, the presence of SIPS mononu-
clear cells in hemodialysis patients may be the result of
increased replicative stress induced by the hemodialy-
sis membrane. Membranes that are less biocompatible
induce selective activation of mononuclear cells, which
may lead to SIPS. In contrast, exposure of mononu-
clear cells to membranes that are more biocompatible
results in only mild cell activation that does not result in
SIPS.
Various authors agree that hemodialysis patients suffer
from a chronic inflammatory state [1–3]. This is caused
by various stimuli that act simultaneously to activate
mononuclear cells, leading to the subsequent inflamma-
tory response. An illustration of the collaborative ef-
fect of several stimuli acting on the mononuclear cell
of hemodialysis patients is shown in Figure 4. Cytom-
chrome c oxidase (COX) activation, the most important
intracellular pathway mediating proinflammatory activ-
ity, was evaluated in normal mononuclear cells incu-
bated with uremic serum and lipopolysaccharide (LPS)
in the presence of either cellulosic (Hemophan, Gambro,
Germany) or non-cellulosic (AN-69; Hospal, France)
hemodialysis membranes. Compared with AN-69, the
hemophan membrane produced an increase in the pro-
duction of COX messenger RNA, COX protein, and
prostaglandin E (PGE).
The percentage of SIPS mononuclear cells in hemo-
dialysis patients treated with cellulosic membranes
correlated significantly with serum levels of C-reactive
protein, a parameter that reflects inflammatory activ-
ity (data not shown). This finding supports the theory
that, as observed in other patients with chronic inflam-
matory diseases, hemodialysis patients maintain a large
percentage of senescent mononuclear cells in peripheral
blood, which is associated with the chronic inflammatory
state.
Moreover, we have observed that SIPS mononuclear
cells from our hemodialysis patients exhibit increased
levels of intracytoplasmic proinflammatory cytokines,
suggesting that SIPS cells are preactivated mononu-
clear cells. In vitro, these cells release large amounts of
proinflammatory cytokines in response to substimulatory
doses of LPS or bacterial DNA. These results suggest
that these cells contribute to a chronic inflammatory state.
Nevertheless, according to our data, SIPS mononuclear
cells in hemodialysis patients are both the cause and the
consequence of chronic inflammation.
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Fig. 3. (A) Representative studies showing telomere length and apop-
tosis in a sample of mononuclear cells from a hemodialysis patient in-
cluded in the study. Mononuclear cells with long telomeres show a small
percentage of apoptosis, whereas most of the mononuclear cells with
short telomeres undergo apoptosis in vitro. (B) Mean telomere length of
mononuclear cells from predialysis patients and hemodialysis patients
treated with cellulosic or noncellulosic hemodialysis membranes. Mean
telomere length is decreased in mononuclear cells from hemodialysis
patients treated with cellolosic membranes as compared with noncellu-
losic and predialysis patients.
SIPS IN RENAL TRANSPLANTS
A subpopulation of lymphocytes (17% ± 8%) with
short telomeres is found in renal transplant patients even
when renal function is close to normal (a serum creatinine
concentration less than 2 mg/dL). Analysis of telomere
length of mononuclear cells revealed no significant dif-
ference between those of renal transplant patients and
healthy individuals. Other authors have reported simi-
lar observations [17]. Although uremia was no longer
present in these patients, there are other factors such
as the immune response to the graft and the immuno-
suppression therapy, which may explain the activation
of lymphocytes and subsequent development of SIPS.
a: AN-69 S membrane
b: Hemophan membrane
a b
COX2
Actin
COX2 RNAm
synthesis
COX2 protein
expression
a b
70 kD
900
a b
600
300
0
PGE2 (pg/mL) in
culture supernatant
Fig. 4. Mononuclear cells from a healthy patient cultured with uremic
serum and LPS in the presence of a cellulosic membrane (hemophan)
exhibit a high degree of proinflammatory activity as illustrated by the
high expression of COX messenger RNA and protein, and the increased
production of PGE2. However, when these cells were cultured under
the same conditions, but in the presence of noncellulosic membranes
(AN-69), only a low degree of inflammatory response is observed.
It remains to be clarified whether SIPS is restricted to
lymphocytes showing evidence of chronic activation, and
whether the presence of SIPS lymphocytes in transplant
recipients has clinical significance.
CONCLUSION
In CKD patients, immunocompetent cells undergo
SIPS, a process associated with chronic cell activa-
tion. Uremia, hemodialysis therapy, and infections cause
immunocompetent cell activation and premature senes-
cence. Each type of immunocompetent cell reacts differ-
ently to the various stimuli present in the uremic patient.
In predialysis patients, SIPS is observed in lymphocytes;
in contrast, in hemodialysis patients, mononuclear cells
exposed to the hemodialysis membrane are chronically
activated and develop SIPS. In transplant patients, we ob-
served a subpopulation of SIPS lymphocytes that may be
the result of major histocompatibility complex (MHC) in-
compatibility and immunosuppressive therapy. As SIPS
immunocompetent cells are activated cells with proin-
flammatory activity and live longer in peripheral blood,
it is our belief that the accumulation of these cells con-
tributes substantially to the chronic inflammatory state
of CKD patients.
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